PLEXUS CORP

CEO Kelsey Todd’s 1,500‑share sale at Plexus shows steady, Rule 10b5‑1‑planned divestiture—no price impact, just routine insider liquidity.

CEO sells Plexus shares at premium—insider liquidity move, not a signal of doom. Understand how earnings guidance, supply‑chain risks, and defense contracts shape the stock’s outlook.

CEO Kelsey Todd sells 1,000 Plexus shares at $290—an example of wealth‑preservation amid a 114% YTD rally, but it’s unlikely to shake the company’s EMS‑driven growth prospects.

Insider Karen Rapp sells 1,000 Plexus shares at $270—part of a disciplined plan amid 9.56% MoM gains and a 118.76% YTD rally, showing no sign of distress.

Discover how Plexus Corp’s CFO’s 5 May trade reflects a tactical rebalancing rather than a warning sign, and what it means for investors and the company’s future.

Explore how Plexus Corp.’s CEO’s recent insider sales signal portfolio moves, not panic, amid a bull market and growing defense‑sector upside.

Insider selling at Plexus Corp. shows CEO Kelsey Todd’s gradual divestiture, sparking investor concerns. The article links this trend to Plexus’s tech strategy—micro‑services, AI ops, and hybrid cloud—to gauge future growth and share‑price resilienc…

Insider sales at Plexus Corp. reveal routine portfolio moves, not strategic shifts, as the company’s earnings boost keeps the stock on an upward trend.

Quadracci’s recent Plexus share purchase signals strong insider confidence; with cutting‑edge Eclipse platform and rising defense contracts, Plexus shows robust growth potential.

Insider sale of 5,000 Plexus Corp shares by executive FOATE DEAN A shows a large liquidity move amid a neutral market buzz, but the company’s strong earnings, EMS growth and defense contracts still support its bullish outlook.